COXSACKIE B SERIES CF ANTIGENS

Antigens, Cf (including Cf Control), Coxsackievirus A 1-24, B 1-6

HILLCREST BIOLOGICALS

The following data is part of a premarket notification filed by Hillcrest Biologicals with the FDA for Coxsackie B Series Cf Antigens.

Pre-market Notification Details

Device IDK850003
510k NumberK850003
Device Name:COXSACKIE B SERIES CF ANTIGENS
ClassificationAntigens, Cf (including Cf Control), Coxsackievirus A 1-24, B 1-6
Applicant HILLCREST BIOLOGICALS 10703 PROGRESS WAY Cypress,  CA  90630
ContactLouis C Cullman
CorrespondentLouis C Cullman
HILLCREST BIOLOGICALS 10703 PROGRESS WAY Cypress,  CA  90630
Product CodeGNG  
CFR Regulation Number866.3145 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received1985-01-02
Decision Date1985-03-05

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.